Nicox
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1996-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.nicox.com
ADenoVirus Initiative Study in Epidemiology in Italy
Completed
- Conditions
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2017-02-16
- Lead Sponsor
- NicOx
- Target Recruit Count
- 241
- Registration Number
- NCT03055065
- Locations
- 🇮🇹
Clinica oculistica / Ospedale san Paolo, Milano, Italy
Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2017-01-04
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- NicOx
- Registration Number
- NCT03009799
- Locations
- 🇪🇸
Hospital Clinico San Carlos, Madrid, Spain
ADenoVirus Initiative Study in Epidemiology in Spain
Completed
- Conditions
- First Posted Date
- 2014-10-01
- Last Posted Date
- 2017-01-10
- Lead Sponsor
- NicOx
- Target Recruit Count
- 386
- Registration Number
- NCT02254330
- Locations
- 🇪🇸
Instituto de MicrocirugÃa Ocular, Barcelona, Spain
🇪🇸Clinica Barraquer, Barcelona, Spain
🇪🇸Hospital La Paz, Madrid, Spain
ADenoVirus Initiative Study in Epidemiology in UK
Completed
- Conditions
- First Posted Date
- 2014-04-14
- Last Posted Date
- 2015-10-20
- Lead Sponsor
- NicOx
- Target Recruit Count
- 31
- Registration Number
- NCT02112773
- Locations
- 🇬🇧
Queen Alexandra Hospital, Portsmouth, United Kingdom
ADenoVirus Initiative Study in Epidemiology in France
Completed
- Conditions
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2015-02-10
- Lead Sponsor
- NicOx
- Target Recruit Count
- 357
- Registration Number
- NCT02054234
- Locations
- 🇫🇷
CHRU de Lille, Lille, France
🇫🇷Hôpital Kremlin-Bicêtre, Le Kremlin-Bicêtre, France
🇫🇷Groupe hospitalier Pellegrin, Bordeaux, France
ADenoVirus Initiative Study in Epidemiology in Germany
Completed
- Conditions
- First Posted Date
- 2014-02-04
- Last Posted Date
- 2017-01-11
- Lead Sponsor
- NicOx
- Target Recruit Count
- 240
- Registration Number
- NCT02054273
- Locations
- 🇩🇪
University eye hospital Freiburg, Freiburg, Germany
🇩🇪Uwe Pleyer, Berlin, Germany
🇩🇪Florian Seidensticker, Hannover, Germany
Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in Male
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-07-28
- Last Posted Date
- 2011-08-11
- Lead Sponsor
- NicOx
- Target Recruit Count
- 24
- Registration Number
- NCT01404598
Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-28
- Last Posted Date
- 2011-06-17
- Lead Sponsor
- NicOx
- Target Recruit Count
- 31
- Registration Number
- NCT00909519
A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function
- First Posted Date
- 2008-05-08
- Last Posted Date
- 2009-01-28
- Lead Sponsor
- NicOx
- Target Recruit Count
- 32
- Registration Number
- NCT00674856
To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential Hypertension
- First Posted Date
- 2008-04-21
- Last Posted Date
- 2011-06-17
- Lead Sponsor
- NicOx
- Target Recruit Count
- 300
- Registration Number
- NCT00662896
© Copyright 2024. All Rights Reserved by MedPath